$VRSN
VeriSign, Inc

2020 Q4 Form 10-Q Financial Statement

#000101447320000034 Filed on October 22, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q3
Revenue $320.3M $317.9M $308.4M
YoY Change 3.16% 3.07% 0.86%
Cost Of Revenue $46.00M $45.02M $44.44M
YoY Change -1.08% 1.31% -7.89%
Gross Profit $274.3M $272.9M $264.0M
YoY Change 3.86% 3.36% 2.5%
Gross Profit Margin 85.64% 85.84% 85.59%
Selling, General & Admin $50.40M $46.50M $43.74M
YoY Change 0.0% 6.3% -10.4%
% of Gross Profit 18.37% 17.04% 16.57%
Research & Development $19.40M $19.71M $14.62M
YoY Change 28.48% 34.81% 6.61%
% of Gross Profit 7.07% 7.22% 5.54%
Depreciation & Amortization $11.90M $11.70M $11.40M
YoY Change -0.83% 2.63% -7.32%
% of Gross Profit 4.34% 4.29% 4.32%
Operating Expenses $69.80M $66.21M $58.36M
YoY Change 6.56% 13.44% -6.67%
Operating Profit $204.5M $206.6M $205.6M
YoY Change 2.97% 0.5% 5.45%
Interest Expense -$22.20M $22.54M $22.63M
YoY Change 29.07% -0.42% 0.01%
% of Operating Profit -10.86% 10.91% 11.01%
Other Income/Expense, Net -$200.0K $775.0K $10.50M
YoY Change -107.14% -92.62% 76.88%
Pretax Income $182.9M $184.9M $193.5M
YoY Change -1.14% -4.44% 8.51%
Income Tax $25.60M $13.91M $39.57M
% Of Pretax Income 14.0% 7.52% 20.45%
Net Earnings $157.3M $171.0M $153.9M
YoY Change 6.07% 11.09% 11.79%
Net Earnings / Revenue 49.11% 53.79% 49.9%
Basic Earnings Per Share
Diluted Earnings Per Share $1.379M $1.490M $1.298M
COMMON SHARES
Basic Shares Outstanding 114.1M shares 114.7M shares 118.2M shares
Diluted Shares Outstanding 114.8M shares 118.6M shares

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.167B $1.150B $1.230B
YoY Change -4.19% -6.5% 4.33%
Cash & Equivalents $401.2M $145.7M $109.3M
Short-Term Investments $766.0M $1.005B $1.121B
Other Short-Term Assets $2.245M $55.77M $68.14M
YoY Change 36.97% -18.15% 19.5%
Inventory
Prepaid Expenses $17.92M $22.03M $22.03M
Receivables $4.642M $6.356M $4.142M
Other Receivables $0.00 $0.00 $4.000M
Total Short-Term Assets $1.218B $1.206B $1.298B
YoY Change -4.74% -7.09% 5.03%
LONG-TERM ASSETS
Property, Plant & Equipment $245.6M $248.6M $250.2M
YoY Change -1.88% -0.63% -2.38%
Goodwill $52.53M $52.53M $52.53M
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $37.96M $35.16M $40.33M
YoY Change -4.66% -12.82% 48.95%
Total Long-Term Assets $549.0M $558.2M $588.6M
YoY Change -4.6% -5.17% -9.26%
TOTAL ASSETS
Total Short-Term Assets $1.218B $1.206B $1.298B
Total Long-Term Assets $549.0M $558.2M $588.6M
Total Assets $1.767B $1.764B $1.887B
YoY Change -4.7% -6.49% 0.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.00M $10.00M $6.000M
YoY Change -25.0% 66.67% -68.42%
Accrued Expenses $103.0M $96.00M $107.0M
YoY Change 6.19% -10.28% 8.08%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $988.7M $978.0M $960.9M
YoY Change 2.44% 1.78% 5.17%
LONG-TERM LIABILITIES
Long-Term Debt $1.790B $1.789B $1.787B
YoY Change 0.11% 0.11% 0.17%
Other Long-Term Liabilities $95.49M $101.2M $309.1M
YoY Change -69.46% -67.26% 2.71%
Total Long-Term Liabilities $2.168B $2.173B $2.378B
YoY Change -8.85% -8.63% 0.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $988.7M $978.0M $960.9M
Total Long-Term Liabilities $2.168B $2.173B $2.378B
Total Liabilities $3.157B $3.151B $3.339B
YoY Change -5.59% -5.63% 1.61%
SHAREHOLDERS EQUITY
Retained Earnings -$15.66B -$15.82B -$16.63B
YoY Change -4.95% -4.85% -3.74%
Common Stock $353.0K
YoY Change 0.28%
Preferred Stock
YoY Change
Treasury Stock (at cost) $10.81B $10.00B
YoY Change 8.1% 8.7%
Treasury Stock Shares 239.5M shares 235.4M shares
Shareholders Equity -$1.390B -$1.386B -$1.452B
YoY Change
Total Liabilities & Shareholders Equity $1.767B $1.764B $1.887B
YoY Change -4.7% -6.49% 0.11%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income $157.3M $171.0M $153.9M
YoY Change 6.07% 11.09% 11.79%
Depreciation, Depletion And Amortization $11.90M $11.70M $11.40M
YoY Change -0.83% 2.63% -7.32%
Cash From Operating Activities $195.2M $139.6M $208.1M
YoY Change 0.83% -32.92% 10.99%
INVESTING ACTIVITIES
Capital Expenditures -$6.500M -$15.00M -$11.30M
YoY Change -26.14% 32.74% 3.67%
Acquisitions
YoY Change
Other Investing Activities $240.0M -$116.4M -$644.6M
YoY Change -42.0% -81.94% 2218.71%
Cash From Investing Activities $233.5M -$131.4M -$655.9M
YoY Change -42.35% -79.97% 1594.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -173.8M -169.6M -194.0M
YoY Change -13.1% -12.58% 12.01%
NET CHANGE
Cash From Operating Activities 195.2M 139.6M 208.1M
Cash From Investing Activities 233.5M -131.4M -655.9M
Cash From Financing Activities -173.8M -169.6M -194.0M
Net Change In Cash 254.9M -161.4M -641.8M
YoY Change -36.05% -74.85% 2530.33%
FREE CASH FLOW
Cash From Operating Activities $195.2M $139.6M $208.1M
Capital Expenditures -$6.500M -$15.00M -$11.30M
Free Cash Flow $201.7M $154.6M $219.4M
YoY Change -0.35% -29.54% 10.58%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
VERISIGN INC/CA
dei Entity Central Index Key
EntityCentralIndexKey
0001014473
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000 shares
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-23593
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3221585
dei Entity Address Address Line1
EntityAddressAddressLine1
12061 Bluemont Way,
dei Entity Address City Or Town
EntityAddressCityOrTown
Reston,
dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20190
dei City Area Code
CityAreaCode
703
dei Local Phone Number
LocalPhoneNumber
948-3200
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
VRSN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
114109868 shares
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
145701000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
508196000 USD
CY2020Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1004658000 USD
CY2019Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
709863000 USD
CY2020Q3 us-gaap Other Assets Current
OtherAssetsCurrent
55767000 USD
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
60530000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
1206126000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
1278589000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
248587000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
250283000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
52527000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
52527000 USD
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
76903000 USD
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
87798000 USD
CY2020Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
145000000 USD
CY2019Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
145000000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
35163000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
39812000 USD
CY2020Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
558180000 USD
CY2019Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
575420000 USD
CY2020Q3 us-gaap Assets
Assets
1764306000 USD
CY2019Q4 us-gaap Assets
Assets
1854009000 USD
CY2020Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
198342000 USD
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
209988000 USD
CY2020Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
779666000 USD
CY2019Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
755178000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
978008000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
965166000 USD
CY2020Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
281887000 USD
CY2019Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
278702000 USD
CY2020Q3 us-gaap Senior Long Term Notes
SeniorLongTermNotes
1789453000 USD
CY2019Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
1787565000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
101206000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
312676000 USD
CY2020Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2172546000 USD
CY2019Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2378943000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
3150554000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
3344109000 USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000 shares
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
353730000 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
353157000 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
114262000 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
116715000 shares
CY2020Q3 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
14436409000 USD
CY2019Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
14990011000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15819916000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16477490000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2741000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2621000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-1386248000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-1490100000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1764306000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1854009000 USD
CY2020Q3 us-gaap Revenues
Revenues
317879000 USD
CY2019Q3 us-gaap Revenues
Revenues
308421000 USD
us-gaap Revenues
Revenues
944768000 USD
us-gaap Revenues
Revenues
921118000 USD
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
45024000 USD
CY2019Q3 us-gaap Cost Of Revenue
CostOfRevenue
44443000 USD
us-gaap Cost Of Revenue
CostOfRevenue
134205000 USD
us-gaap Cost Of Revenue
CostOfRevenue
134013000 USD
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8389000 USD
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9857000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
23883000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
32775000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19708000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14619000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
55268000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
45704000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38109000 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
33886000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
111719000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
101065000 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
111230000 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
102805000 USD
us-gaap Costs And Expenses
CostsAndExpenses
325075000 USD
us-gaap Costs And Expenses
CostsAndExpenses
313557000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
206649000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
205616000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
619693000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
607561000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
22537000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
22633000 USD
us-gaap Interest Expense
InterestExpense
67607000 USD
us-gaap Interest Expense
InterestExpense
67899000 USD
CY2020Q3 us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
775000 USD
CY2019Q3 us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
10498000 USD
us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
15262000 USD
us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
34137000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
184887000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
193481000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
567348000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
573799000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13908000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
39568000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-90226000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
109825000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
170979000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
153913000 USD
us-gaap Net Income Loss
NetIncomeLoss
657574000 USD
us-gaap Net Income Loss
NetIncomeLoss
463974000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-383000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
308000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-120000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
392000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
170596000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
154221000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
657454000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
464366000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.49
CY2019Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.30
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
5.70
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
3.90
CY2020Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.49
CY2019Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.30
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
5.68
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
3.89
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
114655000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
118194000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115456000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
118966000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114831000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
118569000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115699000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119410000 shares
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-1400324000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-1425167000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-1490100000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-1385474000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-1386248000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-1451919000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-1386248000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-1451919000 USD
us-gaap Profit Loss
ProfitLoss
657574000 USD
us-gaap Profit Loss
ProfitLoss
463974000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
34463000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
34327000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
36106000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
38237000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
5844000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
10271000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
2638000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2126000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
11107000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
12123000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5912000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-7110000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
27673000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
24563000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
195353000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-26571000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
534962000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
560294000 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
1804541000 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
1523862000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
2093437000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1721661000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36933000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
31498000 USD
us-gaap Payments For Proceeds From Businesses And Interest In Affiliates
PaymentsForProceedsFromBusinessesAndInterestInAffiliates
-20009000 USD
us-gaap Payments For Proceeds From Businesses And Interest In Affiliates
PaymentsForProceedsFromBusinessesAndInterestInAffiliates
8530000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-305820000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-237827000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
603705000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
583485000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
12577000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
13152000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-591128000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-570333000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-506000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-208000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-362492000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-248074000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
517601000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
366753000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
155109000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118679000 USD
us-gaap Interest Paid Net
InterestPaidNet
56860000 USD
us-gaap Interest Paid Net
InterestPaidNet
57074000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
105258000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
75197000 USD
CY2020Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
27162000 USD
CY2019Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
33238000 USD
CY2020Q3 us-gaap Time Deposits At Carrying Value
TimeDepositsAtCarryingValue
4078000 USD
CY2019Q4 us-gaap Time Deposits At Carrying Value
TimeDepositsAtCarryingValue
3924000 USD
CY2020Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
123869000 USD
CY2019Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
149624000 USD
CY2020Q3 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
1004658000 USD
CY2019Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
1040678000 USD
CY2020Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
1159767000 USD
CY2019Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
1227464000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
145701000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
508196000 USD
CY2020Q3 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
9408000 USD
CY2019Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
9405000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
155109000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
517601000 USD
CY2020Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1004658000 USD
CY2019Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
709863000 USD
CY2020Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
1159767000 USD
CY2019Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
1227464000 USD
CY2020Q3 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
1000000000.00 USD
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
100000 USD
CY2020Q3 vrsn Debtinstrumentfairvalueseniornotes2023
Debtinstrumentfairvalueseniornotes2023
757900000 USD
CY2020Q3 vrsn Debtinstrumentfairvalueseniornotes2025
Debtinstrumentfairvalueseniornotes2025
554900000 USD
CY2020Q3 vrsn Senior Notes2027
SeniorNotes2027
585900000 USD
CY2020Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
22032000 USD
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
19818000 USD
CY2020Q3 vrsn Prepaidregistryfeescurrent
Prepaidregistryfeescurrent
22578000 USD
CY2019Q4 vrsn Prepaidregistryfeescurrent
Prepaidregistryfeescurrent
21717000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6356000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1524000 USD
CY2020Q3 vrsn Estimatedcontingentconsiderationreceivable
Estimatedcontingentconsiderationreceivable
0 USD
CY2019Q4 vrsn Estimatedcontingentconsiderationreceivable
Estimatedcontingentconsiderationreceivable
14721000 USD
CY2020Q3 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
4801000 USD
CY2019Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
2750000 USD
CY2020Q3 us-gaap Other Assets Current
OtherAssetsCurrent
55767000 USD
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
60530000 USD
vrsn Contingentconsiderationproceeds
Contingentconsiderationproceeds
20400000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11184000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9133000 USD
CY2020Q3 us-gaap Restricted Cash
RestrictedCash
9408000 USD
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
9405000 USD
CY2020Q3 vrsn Prepaidregistryfeesnoncurent
Prepaidregistryfeesnoncurent
7942000 USD
CY2019Q4 vrsn Prepaidregistryfeesnoncurent
Prepaidregistryfeesnoncurent
7753000 USD
CY2020Q3 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
1254000 USD
CY2019Q4 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
6927000 USD
CY2020Q3 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
5375000 USD
CY2019Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
6594000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
35163000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
39812000 USD
CY2020Q3 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
9100000 USD
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
27000000.0 USD
CY2020Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
10469000 USD
CY2019Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
17177000 USD
CY2020Q3 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
34176000 USD
CY2019Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
33435000 USD
CY2020Q3 us-gaap Customer Deposits Current
CustomerDepositsCurrent
46890000 USD
CY2019Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
52804000 USD
CY2020Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
44106000 USD
CY2019Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
49869000 USD
CY2020Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
33021000 USD
CY2019Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
24318000 USD
CY2020Q3 vrsn Accruedfees
Accruedfees
12419000 USD
CY2019Q4 vrsn Accruedfees
Accruedfees
11529000 USD
CY2020Q3 vrsn Customer Incentives Payable
CustomerIncentivesPayable
10971000 USD
CY2019Q4 vrsn Customer Incentives Payable
CustomerIncentivesPayable
13547000 USD
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6290000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7309000 USD
CY2020Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
198342000 USD
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
209988000 USD
CY2020Q3 vrsn Other Tax Liabilities Noncurrent
OtherTaxLiabilitiesNoncurrent
96190000 USD
CY2019Q4 vrsn Other Tax Liabilities Noncurrent
OtherTaxLiabilitiesNoncurrent
308112000 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5016000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4564000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
101206000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
312676000 USD
us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
191800000 USD
vrsn Additionalsharerepurchaseamountauthorized
Additionalsharerepurchaseamountauthorized
743000000.0 USD
CY2020Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
257000000.0 USD
CY2020Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
505600000 USD
CY2020Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
239500000 shares
CY2020Q3 us-gaap Treasury Stock Value
TreasuryStockValue
10810000000 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
114655000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
118194000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115456000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
118966000 shares
CY2020Q3 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
176000 shares
CY2019Q3 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
375000 shares
us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
243000 shares
us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
444000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114831000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
118569000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115699000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119410000 shares
CY2020Q3 us-gaap Revenues
Revenues
317879000 USD
CY2019Q3 us-gaap Revenues
Revenues
308421000 USD
us-gaap Revenues
Revenues
944768000 USD
us-gaap Revenues
Revenues
921118000 USD
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
644000000.0 USD
CY2020Q3 us-gaap Share Based Compensation
ShareBasedCompensation
12678000 USD
CY2019Q3 us-gaap Share Based Compensation
ShareBasedCompensation
12620000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
36106000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
38237000 USD
CY2020Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
400000 USD
CY2019Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
461000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1420000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1285000 USD
CY2020Q3 us-gaap Share Based Compensation
ShareBasedCompensation
12678000 USD
CY2019Q3 us-gaap Share Based Compensation
ShareBasedCompensation
12620000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
36106000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
38237000 USD
CY2020Q3 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
805000 USD
CY2019Q3 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
6457000 USD
us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
7500000 USD
us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
21045000 USD
CY2020Q3 vrsn Incomefromtransitionservices
Incomefromtransitionservices
0 USD
CY2019Q3 vrsn Incomefromtransitionservices
Incomefromtransitionservices
3750000 USD
vrsn Incomefromtransitionservices
Incomefromtransitionservices
2100000 USD
vrsn Incomefromtransitionservices
Incomefromtransitionservices
11850000 USD
CY2020Q3 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-9000 USD
CY2019Q3 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
64000 USD
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
5602000 USD
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
817000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-21000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
227000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
60000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
425000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
775000 USD
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10498000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
15262000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
34137000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13908000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
39568000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-90226000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
109825000 USD
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.08 Rate
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.20 Rate
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.16 Rate
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.19 Rate
CY2020Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 Rate
us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
191800000 USD
CY2020Q1 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
167800000 USD

Files In Submission

Name View Source Status
0001014473-20-000034-index-headers.html Edgar Link pending
0001014473-20-000034-index.html Edgar Link pending
0001014473-20-000034.txt Edgar Link pending
0001014473-20-000034-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vrsn-20200930.htm Edgar Link pending
vrsn-20200930.xsd Edgar Link pending
vrsn-20200930_cal.xml Edgar Link unprocessable
vrsn-20200930_def.xml Edgar Link unprocessable
vrsn-20200930_htm.xml Edgar Link completed
vrsn-20200930_lab.xml Edgar Link unprocessable
vrsn-20200930_pre.xml Edgar Link unprocessable
vrsn-2020930x10qxex1001.htm Edgar Link pending
vrsn-2020930x10qxex3102.htm Edgar Link pending
vrsn-2020930x10qxex3201.htm Edgar Link pending
vrsn-2020930x10qxex3202.htm Edgar Link pending
vrsn-2020x930x10qxex31.htm Edgar Link pending